Name | WAY-380496 |
---|---|
Synonyms |
(4E)-2-(3,4-Dimethoxyphenyl)-4-(3-pyridinylmethylene)-1,3-oxazol-5(4H)-one
5(4H)-Oxazolone, 2-(3,4-dimethoxyphenyl)-4-(3-pyridinylmethylene)-, (4E)- (4E)-2-(3,4-Dimethoxyphenyl)-4-(pyridin-3-ylmethylene)-1,3-oxazol-5(4H)-one MFCD01917812 |
Description | DAPK-IN-2 is a DAPK inhibitor. DAPK-IN-2 can be used for the research of cerebral infarction and ischemic diseases[1]. |
---|---|
Related Catalog | |
In Vitro | DAPK-IN-2 (10 μM) 对 DAPK3 有 36% 的抑制作用[1]。 DAPK-IN-2 (1 μM) 对 DAPK3 有 14% 的抑制作用[1]。 |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 460.9±55.0 °C at 760 mmHg |
Molecular Formula | C17H14N2O4 |
Molecular Weight | 310.30 |
Flash Point | 232.6±31.5 °C |
Exact Mass | 310.095367 |
LogP | 2.38 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.601 |